XENE(Xenon Pharmaceuticals Inc.) · 财务报表

XENE(Xenon Pharmaceuticals Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$18.44M$9.43M$0$0$7.50M
毛利润—————
营业利润−$78.99M−$129.14M−$214.05M−$279.30M−$373.07M
净利润−$78.88M−$125.37M−$182.39M−$234.33M−$345.91M
经营现金流−$69.50M−$101.03M−$151.11M−$181.39M−$279.12M
自由现金流−$71.55M−$103.92M−$156.73M−$184.46M−$279.92M
摊薄每股收益$-1.77$-2.06$-2.73$-3.01$-4.36

Xenon Pharmaceuticals Inc. XENE